Home » Topics » BioWorld

BioWorld
RSS

ADEZA SWAPS ASSAY RIGHTS FOR FUNDING

Jan. 7, 1992

IMMUNEX PRESIDENT PREDICTS LOWER EARNINGS

Jan. 7, 1992

SOMATOGEN GETS BRITISH PATENT

Jan. 7, 1992

VERTEX GETS SBIR FOR DRUG RESEARCH

Jan. 6, 1992

IMMUNOMEDICS FILES FOR OFFERING

Jan. 6, 1992

APPOINTMENTS AND ADVANCEMENTS

Jan. 6, 1992

REPLIGEN ACQUIRES MANUFACTURING FACILITY

Jan. 6, 1992

THE YEAR AHEAD: HOT MARKET FUELS BARGAINING POWER

Jan. 6, 1992

LIPOSOME CO. ISSUES PATENT WARNING

Jan. 6, 1992

THE YEAR AHEAD: ANALYSTS MAKE THEIR PICKS

Jan. 3, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...